StrokeDx Raises Oversubscribed $5 Million Seed Prime Round to Advance Next-Generation Stroke Technology

StrokeDx, a pioneering stroke technology company, secures funding to develop and commercialize advanced technologies for safe cerebrovascular monitoring.

PASADENA, Calif.–(BUSINESS WIRE)–StrokeDx, a pioneer in next-generation stroke technology, today announced the successful closing of $5 million in Series Seed Prime funding. The oversubscribed round was led by DigiTx Partners, with participation by Freeflow Ventures and other existing investors with extensive accomplishments across neuroradiology, stroke, and medical devices. David J. Kim, MD, Managing Director of DigiTx Partners, will be joining the board. To date, StrokeDx’s technology has raised almost $10 million, including a National Institutes of Health (NIH) R01 Grant. This latest investment will support further clinical validation of StrokeDx’s groundbreaking technology and the expansion of its commercial efforts.


StrokeDx specializes in developing advanced technologies and software to enable portable, non-invasive, non-radiating cerebrovascular monitoring. The company’s innovative approach offers a unique and highly precise method to survey strokes using next-generation technology developed by Shane Shahrestani, MD, PhD, at the California Institute of Technology (Caltech).

The societal impact of StrokeDx’s technology is profound, offering a scalable solution to improve stroke outcomes for millions of at-risk individuals. By utilizing portable devices, StrokeDx addresses critical issues in healthcare accessibility and equity. Stroke remains a leading cause of death and disability worldwide, and early detection and rapid monitoring are key to improving survival rates and quality of life.

Stroke affects millions globally, leading to significant mortality and long-term disability. This funding enables us to scale our detection and monitoring solution, empowering physicians and their patients with an effective tool for point-of-care cerebrovascular monitoring. Early intervention can significantly reduce the impact of stroke, shifting the focus from treatment to prevention,” said Alexander Ballatori, Co-Founder and CEO of StrokeDx.

We believe in the potential of StrokeDx’s technology to change the diagnostic paradigm and ultimately improve outcomes for stroke patients. By providing accessible, advanced technology, we can reach millions of at-risk individuals, potentially saving countless lives and reducing the burden on healthcare systems around the world,” said David J. Kim, MD, Managing Director of DigiTx Partners.

About StrokeDx: StrokeDx is at the forefront of developing next-generation stroke detection technology. Our mission is to provide early, accurate, and accessible stroke monitoring and detection solutions to improve patient outcomes and reduce the global burden of stroke. For more information, visit www.stroke-dx.com.

Contacts

Alexander Ballatori, CEO of StrokeDx

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.